GlassScriptPhysician profile
Matthew T Bender
NPI 1700183878
$98,898.57
in general payments reported to CMS, 2019-2025
6 companies · $37K in 2025
The $37K reported for 2025 was more than what 93% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,412 · 2020: $30.07 · 2022: $2,030 · 2023: $16K · 2024: $42K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $77K · Travel and Lodging: $16K · Food and Beverage: $2,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,625.00 |
| Travel and Lodging | $16,103.50 |
| Food and Beverage | $2,698.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $94,512.45 | 2019-2025 | Surpass Evolve, Target, Infinity |
| Balt USA, LLC | $2,708.79 | 2022-2025 | Hybrid Guidewire, Optima Coil System, Ballast 088 Long Sheath |
| Medical Device Business Services, INC. | $1,241.70 | 2019 | |
| Qapel Medical INC | $288.11 | 2023 | |
| Penumbra, INC. | $75.47 | 2019 | |
| Kuros Biosciences USA, INC | $72.05 | 2024 | Magnetos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.